Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

de Tute, R.M., Cook, G. orcid.org/0000-0003-1717-0412, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2024) Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplantation. ISSN 0268-3369

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2024 The Author(s). Except as otherwise noted, this author-accepted version of a journal article published in bone marrow transplantation is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/
Keywords: Bone marrow transplantation; Randomized controlled trials; Risk factors; Translational research
Dates:
  • Submitted: 1 August 2023
  • Accepted: 27 November 2023
  • Published (online): 9 January 2024
  • Published: 9 January 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 11 Jan 2024 12:22
Last Modified: 22 Jan 2024 13:10
Status: Published online
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: https://doi.org/10.1038/s41409-023-02164-4
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)